We explored the effects of combination of acupuncture and Chinese medicinal herbs in treating model rats with polycystic ovarian syndrome (PCOS) and to explore whether acupuncture has positive effects on the absorption of salvianolic acid B in the extracts of a Chinese medicine formula when treating the model rats. 60 female Sprague-Dawley (SD) rats were randomly divided into Groups A, B, C, D, E and F, with ten rats in each group. Except Group F, all of the other rats were induced to PCOS with oral administration of letrozole. The rats in Group F served as normal controls. Group A was treated with acupuncture. Group B was treated with oral administration of the extracts of the Chinese medicine formula. Group C was treated with a combination of oral administration of the extracts of Chinese medicine and acupuncture. Group D received western medicine as positive controls. After treatment, the serum levels of follicle stimulating hormone (FSH), luteinizing hormone(LH) and testosterone (T) in each group were detected with the Enzyme-Linked ImmunoSorbent Assay (ELISA) and the serum concentration of salvianolic acid B were determined using High Performance Liquid Chromatography (HPLC).
Introduction
Polycystic ovary syndrome (PCOS), as a heterogeneous endocrine disorder, with a prevalence of about 1/15, is mainly characterized by ovarian hyperandrogenism, hyperinsulinemia from insulin resistance and reduced fecundity (Knochenhauer et al, 1998) . PCOS is a complex endocrine and metabolic syndrome, which is characterized by small ovarian cysts, irregular menstrual cycles, abnormal hair growth, acne, and metabolic problems leading to weight gain (Knochenhauer et al, 1998) . The cysts associated with PCOS cause a hormone imbalance by means of which sufferers have increased male sex hormones. This can disturb ovulation and lead to infertility. Women who suffer from PCOS also have a higher risk of developing hypertension and diabetes (Knochenhauer et al, 1998) .
As early as two thousand years ago, clinical practitioners began to apply acupuncture and Chinese medicinal herbs together to treat various diseases in China (Ren, 1986) . Acupuncture and Chinese medicinal herbs have both been found to significantly regulate the dysfunction of hypothalamic-pituitary-ovarian axis of the female (Chen,1997 However, few researches had explored the effects of combination of acupuncture and Chinese medicinal herbs in treating model rats with PCOS and to explore whether acupuncture has positive effects on the absorption of active compounds in the extracts of Chinese medicinal herbs when treating the model rats. The present study was then designated to explore the effects of combination of acupuncture and Chinese medicinal herbs in treating model rats with PCOS and to explore whether acupuncture has positive effects on the absorption of salvianolic acid B in the extracts of a Chinese medicine formula when treating the PCOS model rats.
Materials and Methods

Preparation of the Extracts of the Chinese Formula
The Chinese formula used to treat PCOS were composed with 30g of Salvia miltiorrhiza Bunge, 35g of Eucommia ulmoides Oliver, 20g of Carthamus tinctorius Linn., 20g of Bupleurum chinense DC., 30g of Gleditsia sinensis Lam. and 20g of Atractylodes lancea( Thunb.)DC. The crude drugs of this formula were extracted by boiling water for 60min to reach the final volume of 1550ml. After filtration, the extraction procedure was repeated once to reach the final volume of 1240mL. All the filtrates were combined and condensed under reduced pressure and freeze dried. The flowchart of the extraction method is shown in Figure 1 . Hangzhou Normal University (Hangzhou, China). The rats with two continuous sexual cycles were selected for this research.
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The research was carried out according to the National Research Council's protocol for the care and use of laboratory animals.
The PCOS model was established by oral administration with letrozole dissolved in 0.5% of carboxymethyl cellulose (CMC, 2ml/kg) for 21 days once daily. 50 rats were orally administered with letrozole at the concentration of 1mg/kg for 21 days.
The 50 rats were randomly divided into five groups with 10 rats in each group to group A, group B, group C, group D and group E. 10 rats were randomly selected as group F received 0.5% of CMC 2ml/kg body weight. The anovulatory PCOS model was confirmed successfully by the observation of the continuous keratinization of vaginal epithelium.
Group A: The rats in Group A were acupunctured at the following acupoints: Jizhong (Du6), Dazhui (Du14) and Zhongwan (Ren12). Both the acupoints and the stainless steel needles were sterilized with 75% alcohol. The rats were anesthetized with sodium pentobarbital (40 mg/kg, i.p.) before acupuncture treatment. The needles were inserted 2 mm into Jizhong (Du6), Dazhui (Du14) and Zhongwan (Ren12) and then were connected to an electro-therapeutic apparatus (Model G6805-2, Shanghai, China) for 15 min through clip electrodes. For the electronic stimulation, high-frequency (100Hz) and low frequency (20Hz) are used interchangeably with intensity ranged between 5mA and 25 mA. Slight twitches of the lower limbs of rats were found. The acupuncture treatment were taken every two days and continued for 28 days.
Group B: The rats in Group B were orally administered with the extracts of the Chinese medicine formula for 28 days dissolved in 0.5% of CMC with the dosage of 2.5g/kg.
Group C: The rats were treated with a combination of oral administration of the extracts of the Chinese medicine formula (2.5g/kg) and acupuncture. 30 mins after the oral administration of the extracts, the rats in Group C were acupunctured at the following acupoints: Jizhong (Du6), Dazhui (Du14) and Zhongwan (Ren12).
Group D: The rats were treated with oral administration of clomifene citrate dissolved in 0.5% of CMC with the dosage of 1mg/kg. Every four to five days make one sexual cycle of rats. At the first and second day of each cycle the rats were orally administered with clomifene citrate once per day. On the third to fifth day of the cycle, the oral administration was stopped. It was 28 days from the first day of oral administration.
Group E: The rats were treated with oral administration with 0.5% of CMC with the dosage of 1mg/kg.
Group F: The rats were treated with oral administration of 0.5% of CMC with the dosage of 1mg/kg.
From the Day 6 of the treatment, the vaginal smears of all the rats were observed to test ovulation. An hour after the treatments for 28 days on Day 50, all the rats in Groups A, B, C, D, E and F were anesthetized with sodium pentobarbital (40 mg/kg, i.p.). The blood samples were taken from hepatic portal vein for the analysis of follicle stimulating hormone (FSH), luteinizing hormone(LH) and testosterone (T) with Enzyme-Linked ImmunoSorbent Assay (ELISA). The blood samples were collected and centrifuged at 3,000 rpm for 10 min. The supernatant serum samples were stored at -20 o C until analysis.
The serum concentration of salvianolic acid B was determined using High Performance Liquid Chromatography (HPLC).
The whole process of the animal treatment is shown in Figure 2 .
Materials
Salvia miltiorrhiza Bunge was purchased from Huqing Yutang Pharmaceutical Co., Ltd (Hangzhou, China) and was identified by Zhejiang Chinese Medicinal University (Hangzhou, China). Salvianolic acid B was purchased from Carbosynth limited, UK. Acetonitrile of HPLC-grade was purchased from TEDIA Co. (OH, USA). Acetic acid and perchloric acid (analytical reagent grade) were purchased from Sinapharm Chemical Reagent Co. Ltd (Shanghai, China). Ultra-pure water (made by Millipore, Bedford, MA, USA) with a resistivity of more than 18 MΩ was used for all the preparations. The ELISA assay kits were provided by Boster Biotehnology Ltd., Wuhan, China.
HPLC conditions
Agilent 1200 SL (Agilent Technologies, Santa Clara, California, USA) was used in the research. The HPLC analysis was achieved by using a reversed-phase HPLC column (Agilent ZORBAX Rx-C18 2.1 x 150mm, 5μm).
Water/acetic acid (0.1 % v/v, pH = 6.0; used as solvent A) and acetonitrile (as solvent B) were used as mobile phase with a linear gradient elution at a flow rate of 0.25 mL/min. The linear gradient elution was as follows: solvent B was increased from 5 to 30% in the first 25 min, then increased to 35% till 40min, increased to 75% till 60min and then increased to 85% at 70 min. The sample injection volume was 20μl. The detection wavelength was set at 280 nm. The column temperature was 25 o C. The solvents were filtered through a 0.45 μm Millipore filter and degassed prior to use.
Figure 2:
The whole process of the research
Preparation of stock and working standard solutions
The standard stock solution was prepared by dissolving 0.69 mg of salvianolic acid B in 10 mL of methanol to obtain a concentration of 69.00 μg/mL. The stock solution was kept at 4°C. The standard working solutions were prepared at various concentrations of 0.01, 0.07, 0.69, 6.90 and 69.00 μg/mL by diluting the stock solution with methanol.
Preparation of the samples
0.2 mL of methol solution was added into 1 mL of serum. The mixture was then vortex-mixed for 2 mins. After centrifugation at 3,000 rpm for 10 mins, the supernatant was filtered through a 0.45 μm membrane filter unit. was plotted with the concentrations as X-axes and the peak areas as Y-axes using linear regression.
Validation of the methods
The samples for calibration curve (n=5) were prepared in the blank serum according to the methods of preparing the calibration standards. A correlation coefficient of more than 0.99 was desirable for the calibration curve. Recovery was determined by adding salvianolic acid B of different concentrations: 0.06, 0.59 and 5.90 μg/mL respectively. The precision (intra-day and inter-day) of the methods was also calculated at the three concentrations above. The precision assay was determined by the variability of the peak areas at each concentration. The accuracy was determined by measuring of concentration with the spiked value. The limit of detection (LOD) was determined at a signal-to-noise of baseline at a ratio of 3:1.
ELISA analysis
The serum levels of FSH, LH, and T were analyzed using ELISA kits according to the instruction.
Statistical analysis
Results were analyzed by an independent university-statistician using the computer software, Statistical Package for Social Sciences (SPSS 13.0 for Windows). Analysis of variance (ANOVA) was used for comparison of the serum concentration of salvianolic acid B and for comparison of the serum levels of FSH, LH, and T. For all hypothesis tests, a 5% significance level p<0.05) and two-tailed tests were used.
Results
Comparison of Serum FSH, LH and T levels and the ratio of LH/FSH.
As shown in Figure 3 , the serum levels of T and the ratio of LH/FSH in Group A, B. C, D, and F were significantly lower than those of Group E, indicating that the model rats with PCOS were successfully established. Compared with Groups A, B, D and E, the serum levels of T and the ratio of LH/FSH in Group C were significantly lower respectively, indicating combination of acupuncture and Chinese medicinal herbs can significantly enhance curative effects in treating model rats with PCOS.
Validation of the method
The regression equations and correlation coefficients ( 
Analysis of the samples
The HPLC chromatogram of a Salvia miltiorrhiza Bunge is shown in Figure 3 . The concentration of the serum salvianolic acid B is shown in Table 1 . The serum concentration of salvianolic acid B in group B was 1.65±0.36μg/mL. The peak serum concentrations of salvianolic acid B in group C was 2.52 ±0.49 μg/mL. The concentration of serum salvianolic acid Group C was significantly higher than Group B, indicating that acupuncture might improve the absorption of salvianolic acid B from the extracts of Salvia miltiorrhiza Bunge in the rats. The study period was defined as the period extending from 3 months before the first electro-acupuncture treatment, to 3 months after the last electro-acupuncture treatment (10-14 treatments), in 8-9 months. The menstrual and ovulation patterns were confirmed by recording of vaginal bleedings and by daily registrations of the basal body temperature (BBT). Blood samples were collected within a week before the first electro-acupuncture, within a week after the last electro-acupuncture and 3 months after electro-acupuncture. The results showed that 38% of the women experienced a good effect. They displayed a mean of 0.66 ovulations/woman and month in the period during and after the electro-acupuncture period compared to a mean of 0.15 before the electro-acupuncture period (p=0.004). Before electro-acupuncture, women with a good effect had a significantly lower body-mass index (BMI) (p<0.001), waist-to-hip circumference ratio (WHR) (p=0.0058), serum testosterone concentration (p=0.0098), serum testosterone/sex hormone binding globulin (SHBG) ratio (p=0.011) and serum basal insulin concentration (p=0.0054), and a significantly higher concentration of serum SHBG (p=0.040) than did those women with no effect. It was the concluded that the repeated electro-acupuncture treatments induce regular ovulations in more than one third of the women with PCOS. The group of women with good effect had a less androgenic hormonal profile before treatment and a less pronounced metabolic disturbance compared with the group with no effect. For this selected group, electro-acupuncture offers an alternative to pharmacological ovulation induction. Together with changes in diet and rational exercise, use of the combination of acupuncture and Chinese medicinal herbs are supposed to empower PCOS women to lead a better quality of lives.
Conclusion
Combination of acupuncture and Chinese medicinal herbs significantly enhanced curative effects in treating model rats with PCOS and acupuncture had positive effects in improving the absorption of salvianolic acid B in the extracts of the Chinese medicine formula when treating the model rats with PCOS.
